September 14, 2020
Public Wants Greater Focus on Science-Based Decision-Making Says New International Survey from Philip Morris International
- Majority of adults surveyed believe science can solve critical global challenges.
- However, only half of respondents believe governments are doing a good job in leveraging science to inform decisions.
The global insights reveal that faith in science is high, with most people surveyed (77 percent) hopeful that advances in science will solve many of society’s biggest problems. Supporting this view, there is also strong interest in businesses prioritizing science, with 90 percent of respondents saying it is important to them that businesses invest continually in science to improve their products.
Despite these positive attitudes, nearly half of respondents (47 percent) believe that society does not place enough importance on science. Given the diverging opinions, the white paper challenges the need for regulators to place greater focus on science to inform policy decisions, with half (51 percent) of respondents believing that their “government does a good job ensuring science and evidence are included in the decision-making process.”
“Science can help make significant strides in our collective efforts to address the world’s most pressing problems” said Dr.
The survey also reveals that people’s access to accurate scientific information is far from assured today, with nearly half of the total sample indicating that they find it difficult to access reliable information about scientific developments and relevant studies.
“This finding is alarming and sends a clear signal across business, media, and government that accurately communicating scientific information should remain an important priority,” added
PMI is undergoing a fundamental transformation into a science- and technology-led company with the aim of delivering a smoke-free future—a future without cigarettes. With the right regulatory encouragement and support from civil society, we believe this goal can be achieved in many countries in 10 to 15 years. Science is central to delivering on this commitment. Since 2008, PMI has invested billions of dollars in developing, testing, and manufacturing better alternatives to cigarettes for adults who would otherwise continue to smoke. These products are the result of nearly two decades of R&D work, underpinned by a rigorous scientific assessment program and led by a team that today includes more than 430 world-class scientists and other experts. We make our scientific findings and methods available for others to scrutinize, we invite independent research into our products, and we encourage a broad, science-based conversation with regulators, scientists, and the public health community about these better alternatives and the role they can play in tobacco control and harm reduction.
To read the “In Support of the Primacy of Science” paper, visit https://www.pmi.com/primacyofscience.
Povaddo conducted this online survey on behalf of PMI
T. +41 (0)79 843 8603